TABLE 1.
Primers used in this study
| Primersa | Sequence (5′–3′)b | Restriction site |
|---|---|---|
| HA-NCL-F HA-NCL-R HA-NCL (546-699)-F HA-NCL (1-545)-R NCL-GFP-F NCL-GFP-R Fibrillarin-GFP-F Fibrillarin-GFP-R |
TGGCCATGGAGGCCCGAATTCGGATGGCTCCTCCTCCAAAGGAGGTG GATCCCCGCGGCCGCGGTACCTTATTCAAACTTCGTCTTCTTTCC TGGCCATGGAGGCCCGAATTCGGGGACCCAGGGGATCGCCTAATG GATCCCCGCGGCCGCGGTACCTTATTGTAACTCCAGCCTGATTGT GAGGTTTAAACTACGGGATCCAATGGCTCCTCCTCCAAAGGAGGTG ACCGGTAGCGCTAGGACGCGTAATTCAAACTTCGTCTTCTTTCCT GAGGTTTAAACTACGGGATCCAATGAAGCCAGGTTTCAGCCCCC ACCGGTAGCGCTAGGACGCGTAAGTTCTTCACCTTCGGAGGCGG |
EcoRI KpnI EcoRI KpnI BamHI MluI BamHI MluI |
F denotes forward primer; R denotes reverse primer.
Restriction sites are underlined.